Jan Vanco

Docent

Palacký University, Olomouc
Country flagCzech Republic

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (20)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

A series of eight N ‐heterocyclic carbenes (NHC) gold(I) complexes, involving 1,3‐bis(2,6‐diisopropylphenyl)imidazol‐2‐ylidene (iPr) ligand in combination with 6‐mercaptopurine derivatives (HL 1–8 ), has been prepared and thoroughly characterized, including elemental analysis, mass spectrometry, infrared and multinuclear NMR spectroscopy, and single crystal X‐ray analysis. The complexes, showing general composition of [Au (iPr)(L n )] 1 – 8 , were evaluated for their in vitro cytotoxicity against four human cancer cell lines including A2780 (ovarian) and A2780R (ovarian Cisplatin resistant), PC3 (prostate) and MCF‐7 (breast), and normal human MRC‐5 cells (lung fibroblasts). The complexes revealed significant cytotoxicity, with the best IC 50 values ≈ 3.4–6.4 μM against A2780 and reasonable selectivity. Cellular effects of the selected complexes on the A2780 cells were evaluated using various flow cytometry assays. Complexes 1 , 3 , and 4 showed a strong pro‐apoptotic effect and a strong effect on the loss of mitochondrial membrane potential. These findings indicate that their major mechanism of action is based on the collapse of the mitochondrial metabolism and activation of the intrinsic signaling pathway of apoptosis, consequently resulting in cell death. The complexes 1 – 8 revealed only negligible effect on the production of inflammatory‐related cytokine (TNF‐α), as well as the activation of nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB) or peroxisome proliferator‐activated receptor gamma (PPARγ). Moreover, the shotgun proteomic analysis was performed, and the obtained results suggest that the mechanism of action of complexes 1 , 3 , and 4 differs somewhat from that of Auranofin .

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (11)

Lorenzo Biancalana

University of Pisa

ITALY
View details

FABIO MARCHETTI

Full Professor (Professore Ordinario)

University of Pisa

ITALY
View details

Stefano Zacchini

Professor

University of Bologna

ITALY
View details

Tarita Biver

Associate Professor

University of Pisa

ITALY
View details

Jaromir Marek

associate professor

Masaryk University

CZECH REPUBLIC
View details

Johannes A Schmid

Full Professor

Medical University of Vienna

AUSTRIA
View details

Zdeněk Trávníček

Head of the Division

Palacký University, Olomouc

CZECH REPUBLIC
View details

Jan Hošek

associate professor

Masaryk University

CZECH REPUBLIC
View details

Giorgio Zoppellaro

Senior scientist

VSB - Technical University of Ostrava

CZECH REPUBLIC
View details

Zdeněk Dvořák

Palacký University, Olomouc

CZECH REPUBLIC
View details

Rene Lenobel

senior researcher

Palacký University, Olomouc

CZECH REPUBLIC
View details